Belgium’s UCB to Divest Chinese Neurology and Allergy Business for $680 Million
UCB, the Brussels-based biopharmaceutical giant, has announced its decision to sell its Chinese neurology and...
Wall Street Market News
UCB, the Brussels-based biopharmaceutical giant, has announced its decision to sell its Chinese neurology and...